Mannkind (MNKD) Times Interest Earned (2010 - 2026)
Mannkind (MNKD) posted quarterly Times Interest Earned of -$0.1 for Q1 2026, down 104.6% year-over-year from $2.1 in Q1 2025, and up 82.61% quarter-over-quarter from -$0.55 in Q4 2025.
Mannkind (MNKD) Times Interest Earned (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Times Interest Earned for 17 consecutive years, with -$0.1 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned fell 104.6% year-over-year to -$0.1; the TTM figure through Mar 2026 stood at $0.86 (down 34.77% YoY), while the FY2025 annual figure was $1.02, down 46.61% from the prior year.
- Times Interest Earned advanced to -$0.1 in Q1 2026 per MNKD's latest filing, from -$0.55 in the prior quarter.
- Across five years, Times Interest Earned topped out at $5.72 in Q3 2025 and bottomed at -$7.74 in Q1 2022.
- Historically, Times Interest Earned has averaged -$0.18 across 5 years, with a median of $0.62 in 2023.
- Annual changes were most pronounced in 2022 — Times Interest Earned plunged 706.12% — and 2024, when it surged 415.09%.
- Mannkind's Times Interest Earned stood at -$3.45 in 2022, then jumped by 117.96% to $0.62 in 2023, then jumped by 55.2% to $0.96 in 2024, then plunged by 157.65% to -$0.55 in 2025, then jumped by 82.61% to -$0.1 in 2026.
- Business Quant data shows MNKD's Times Interest Earned at -$0.1 in Q1 2026, -$0.55 in Q4 2025, and $5.72 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.55 |
| Sep 30, 2025 | 5.72 |
| Jun 30, 2025 | 0.86 |
| Mar 31, 2025 | 2.10 |
| Dec 31, 2024 | 0.96 |
| Sep 30, 2024 | 1.53 |
| Jun 30, 2024 | 1.29 |
| Mar 31, 2024 | 1.81 |
| Dec 31, 2023 | 0.62 |
| Sep 30, 2023 | 1.81 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | -1.62 |
| Dec 31, 2022 | -3.45 |
| Sep 30, 2022 | -3.42 |
| Jun 30, 2022 | -3.08 |
| Mar 31, 2022 | -7.74 |
| Dec 31, 2021 | -52.56 |
| Sep 30, 2021 | -2.35 |